Type 2 & other diabetes

Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)

Lancet Diabetes EndocrinolPublished Cross-sectional study

Authors' conclusion

The prevalence of diabetes and other metabolic NCDs in India is considerably higher than previously estimated. While the diabetes epidemic is stabilising in the more developed states of the country, it is still increasing in most other states. Thus, there are serious implications for the nation, warranting urgent state-specific policies and interventions to arrest the rapidly rising epidemic of metabolic NCDs in India.

Study context

Population
Individuals aged ≥20 years from urban and rural areas of 31 states, union territories and the National Capital Territory of India, 2008–2020
Participants
113,043 individuals
Exposure
Rural vs Urban
  • Ruraln = 79,506
  • Urbann = 33,537
Outcome
Weighted prevalence of metabolic NCDs: diabetes, prediabetes, hypertension, generalised and abdominal obesity, dyslipidaemia
Methodological detailspopulation-based, stratified multistage sampling, multiphase, Survey conducted in multiple phases between Oct 18, 2008 and Dec 17, 2020, Stratified multistage sampling with three-level stratification by geography, population size and socioeconomic status, Diagnostic criteria: WHO (diabetes, prediabetes), Eighth Joint National Committee (hypertension), WHO Asia Pacific (generalised and abdominal obesity), National Cholesterol Education Program-Adult Treatment Panel III (dyslipidaemia)
  • Population-based
  • Stratified multistage sampling
  • Multiphase
  • Survey conducted in multiple phases between Oct 18, 2008 and Dec 17, 2020
  • Stratified multistage sampling with three-level stratification by geography, population size and socioeconomic status
  • Diagnostic criteria: WHO (diabetes, prediabetes), Eighth Joint National Committee (hypertension), WHO Asia Pacific (generalised and abdominal obesity), National Cholesterol Education Program-Adult Treatment Panel III (dyslipidaemia)

Main finding

As reported in the abstract

Overall weighted prevalence of metabolic NCDs
Diabetes (10 151 of 107 119), 95% CI 10.2-12.5
11.4%
Prediabetes (15 496 of 107 119), CI 13.9-16.6
15.3%
Hypertension (35 172 of 111 439), CI 33.8-37.3
35.5%
Generalised obesity (29 861 of 110 368), CI 26.9-30.3
28.6%
Abdominal obesity (40 121 of 108 665), CI 37.7-41.4
39.5%
Dyslipidaemia (14 895 of 18 492 of 25 647), CI 77.9-84.5
81.2%

Observational data: associations, not effects.

Further findings

Urban vs rural

All metabolic non-communicable disease (NCDs) except prediabetes more frequent in urban than rural areas

Diabetes to prediabetes ratio

Ratio <1 in many states with lower human development index

Original publication

Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. Published 7 June 2023. doi:10.1016/s2213-8587(23)00119-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.